PADTAK PEDIATRIC DEFIB/CARDIOVERT/PACE/MONITOR-RADIOTRANSPARENT (2X2.25),MODEL 2602, PADTAK PEDIATRIC DEFIB/CARDIOVERT

K983232 · Tz Medical, Inc. · DRO · Sep 15, 1999 · Cardiovascular

Device Facts

• Record ID: K983232
• Device Name: PADTAK PEDIATRIC DEFIB/CARDIOVERT/PACE/MONITOR-RADIOTRANSPARENT (2X2.25),MODEL 2602, PADTAK PEDIATRIC DEFIB/CARDIOVERT
• Applicant: Tz Medical, Inc.
• Product Code: DRO · Cardiovascular
• Decision Date: Sep 15, 1999
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 870.5550
• Device Class: Class 2
• Attributes: Therapeutic, Pediatric

Intended Use

PadTac Pediatric disposable electrodes are used by trained professionals in hospitals, doctors offices and Emergency Medical Services for pediatric low-energy defibrillation, cardioversion and monitoring.

Device Story

PadTac Pediatric electrodes are disposable, patient-applied interfaces designed for pediatric low-energy defibrillation, cardioversion, and monitoring. Operated by trained professionals in clinical settings (hospitals, doctors' offices) and EMS environments. Electrodes facilitate electrical signal transmission between patient and external defibrillator/monitor units. Device enables healthcare providers to deliver therapeutic energy or monitor cardiac rhythms in pediatric populations. Benefits include standardized, disposable interface for emergency cardiac care.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Disposable pediatric electrodes for defibrillation, cardioversion, and monitoring. Form factor designed for pediatric application. Non-sterile or sterile (not specified). No software or active electronic components; passive conductive interface.

Indications for Use

Indicated for pediatric patients requiring low-energy defibrillation, cardioversion, and monitoring. For use by trained professionals in hospitals, doctors' offices, and Emergency Medical Services.

Regulatory Classification

Identification

An external transcutaneous cardiac pacemaker (noninvasive) is a device used to supply a periodic electrical pulse intended to pace the heart. The pulse from the device is usually applied to the surface of the chest through electrodes such as defibrillator paddles.

Special Controls

*Classification.* Class II. The special controls for this device are:(1) “American National Standards Institute/American Association for Medical Instrumentation's DF-21 ‘Cardiac Defibrillator Devices’ ” 2d ed., 1996, and (2) “The maximum pulse amplitude should not exceed 200 milliamperes. The maximum pulse duration should not exceed 50 milliseconds.”

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three horizontal lines above it, all enclosed within a circle. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper portion of the circle.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

SEP | 5 1999

Mr. Byron Zahler TZ Medical, Inc. 15858 S.W. Upper Boones Ferry Road Lake Oswego, OR 97035

K983232 Re: PADTAK Pediatric Defib/Cardiovert/Pace/Monitoring Electrodes Requlatory Class: III (three) 74 DRO Product Code: Dated: June 8, 1999 Received: June 11, 1999

Dear Mr. Zahler:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Druq, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{1}------------------------------------------------

## Page 2 - Mr. Byron Zahler

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone], or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Thomas J. Callahan

Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

V

Enclosure

{2}------------------------------------------------

¥983232

Device Name:

510(k) Number (if known)__

PadTac Pediatric Defibrillate/Cardiovert/Pace Fadrac Pedial::trodes from TZ Medical Inc.

Indications For Use:

PadTac Pediatric disposable electrodes are used by trained professionals in hospitals,
PadTac Pediatric Madian Madian Camines for nediatric low-energy PadTac Pediathe disposable electrouse are pediatric low-energy
doctors offices and Emergency Medical Services for pediatric low-energy doctors offices and Emergency Modical Cornersion and monitoring.

Please do not WRITE BELOW THIS LINE - CONTINUE on another Page IF NEEDED)

Concurrence Of CDRH, Office OF Device Evaluation (ODE)

M. Ryle

(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices

510(k) Number

escription Use
X
(Per 21 CFR 801.109)

Over-The-Counter Use_

(Optional Format 1-2-96)

్ర